Related references
Note: Only part of the references are listed.Prevalence of use and acute toxicity associated with the use of NBOMe drugs
David M. Wood et al.
CLINICAL TOXICOLOGY (2015)
New phenethylamines in Europe
L. A. King
DRUG TESTING AND ANALYSIS (2014)
Mind-altering drugs and research: from presumptive prejudice to a Neuroscientific Enlightenment? Science & Society series on Drugs and Science
David Nutt
EMBO REPORTS (2014)
Emerging Drugs of Abuse
Michael E. Nelson et al.
EMERGENCY MEDICINE CLINICS OF NORTH AMERICA (2014)
A meta-analytic clarification of the relationship between posttraumatic growth and symptoms of posttraumatic distress disorder
Jane Shakespeare-Finch et al.
JOURNAL OF ANXIETY DISORDERS (2014)
Effects of neuronal nicotinic acetylcholine receptor allosteric modulators in animal behavior studies
Anshul A. Pandya et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Neurochemical profiles of some novel psychoactive substances
Les Iversen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
A Cluster of Deaths Involving 5-(2-Aminopropyl)Indole(5-IT)
Robert Kronstrand et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2013)
Four Fatalities Involving 5-IT
L. Nitin Seetohul et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2013)
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study
Michael C. Mithoefer et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
A randomized, controlled pilot study of MDMA (+/- 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)
Peter Oehen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Monoamine neurocircuitry in depression and strategies for new treatments
Michel Hamon et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Molecular Pharmacology and Ligand Docking Studies Reveal a Single Amino Acid Difference between Mouse and Human Serotonin 5-HT2A Receptors That Impacts Behavioral Translation of Novel 4-Phenyl-2-dimethylaminotetralin Ligands
Clinton E. Canal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Imaging DA release in a rat model of L-DOPA-induced dyskinesias: A longitudinal in vivo PET investigation of the antidyskinetic effect of MDMA
Nadine Y. Lettfuss et al.
NEUROIMAGE (2012)
PKCα is genetically linked to memory capacity in healthy subjects and to risk for posttraumatic stress disorder in genocide survivors
Dominique J. -F. de Quervain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
α4β2 Nicotinic Acetylcholine Receptors on Dopaminergic Neurons Mediate Nicotine Reward and Anxiety Relief
Tresa M. McGranahan et al.
JOURNAL OF NEUROSCIENCE (2011)
The safety and efficacy of ± 3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study
Michael C. Mithoefer et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Comparative neurochemical profile of 3,4-methylenedioxymethamphetamine and its metabolite alpha-methyldopamine on key targets of MDMA neurotoxicity
E. Escubedo et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
Exit Mechanisms of the Intracellular Bacterium Ehrlichia
Sunil Thomas et al.
PLOS ONE (2010)
The effects of 3,4-methylenedioxymethamphetamine (MDMA) on nicotinic receptors: Intracellular calcium increase, calpain/caspase 3 activation, and functional upregulation
Sara Garcia-Rates et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
Protein kinase C alpha: disease regulator and therapeutic target
Olga Konopatskaya et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview
Joao Paulo Capela et al.
MOLECULAR NEUROBIOLOGY (2009)
Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration
G. J. H. Dumont et al.
SOCIAL NEUROSCIENCE (2009)
Emerging treatments for PTSD
Judith Cukor et al.
CLINICAL PSYCHOLOGY REVIEW (2009)
Norepinephrine Transporter Regulation Mediates the Long-Term Behavioral Effects of the Antidepressant Desipramine
Zaorui Zhao et al.
NEUROPSYCHOPHARMACOLOGY (2008)
MDMA-Assisted Psychotherapy Using Low Doses in a Small Sample of Women with Chronic Posttraumatic Stress Disorder
Jose Carlos Bouso et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2008)
Methamphetamine and 3,4-methylenedioxymethamphetamine interact with central nicotinic receptors and induce their up-regulation
Sara Garcia-Rates et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2007)
MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment
Christopher D. Verrico et al.
PSYCHOPHARMACOLOGY (2007)
Monoamine transporters and psychostimulant drugs
RB Rothman et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Short- and long-term effects of MDMA (ecstasy) on synaptosomal and vesicular uptake of neurotransmitters in vitro and ex vivo
IL Bogen et al.
NEUROCHEMISTRY INTERNATIONAL (2003)
A clinical plan for MDMA (Ecstasy) in the treatment of posttraumatic stress disorder (PTSD): Partnering with the FDA
R Doblin
JOURNAL OF PSYCHOACTIVE DRUGS (2002)
Efficacy and safety of paroxetine treatment for chronic PTSD: A fixed-dose, placebo-controlled study
RD Marshall et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
An exploration of the history and controversies surrounding MDMA and MDA
AR Pentney
JOURNAL OF PSYCHOACTIVE DRUGS (2001)
Share Paper
